Boris Reznik, based in Cambridge, MA, US, is currently a Principal Scientist, Rare Diseases at Moderna, bringing experience from previous roles at Ultragenyx Pharmaceutical Inc., UCSF and UCSF Innovation Ventures. Boris Reznik holds a 2009 - 2012 Doctor of Philosophy (Ph.D.) in Molecular Biology @ University of California, San Diego. With a robust skill set that includes Molecular Biology, Molecular Cloning, Biotechnology, PCR, Biochemistry and more, Boris Reznik contributes valuable insights to the industry. Boris Reznik has 1 email on RocketReach.